BioLife Sciences Inc.
BLFE · OTC
11/30/2020 | 11/30/2019 | 11/30/2018 | 11/30/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,268 | -$1 | -$53 | -$340 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $379 | $1 | $25 | $22 |
| Other Non-Cash | $4 | $0 | -$10 | $300 |
| Operating Cash Flow | -$884 | $0 | -$13 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $876 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $2 | $31 |
| Financing Cash Flow | $876 | $0 | $2 | $31 |
| Forex Effect | $44 | $0 | $0 | $0 |
| Net Chg. in Cash | $35 | -$1 | -$11 | $12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $1 | $12 | $0 |
| End Cash | $35 | $0 | $1 | $12 |
| Free Cash Flow | -$885 | $0 | -$13 | -$19 |